This study is to help find cancer early and check if cancer comes back after treatment. Cancer types include brain, breast, lung, and 17 others. The study uses a special blood test called genome-wide methylome enrichment platform. This test looks at cfDNA, which is tiny pieces of DNA in the blood, to find changes that show cancer. Participants will have blood samples taken and health check-ups. If you have breast, colorectal, lung, or prostate cancer, you'll have follow-ups every 3 months for the first year and every 6 months for the next 2 years. Others will have yearly check-ups for 3 years. The results won't be shared with you or your doctor.
- Participation Length: Up to 3 years with regular follow-ups.
- Eligibility: If you are 40+ and recently diagnosed with certain cancers.
- Exclusion: Currently on cancer treatment or certain medications.
How understandable was the trial content above?
Hard to understand
Easy to understand